Prognosis of β-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.

CONCLUSION: β-blocker of esmolol is safe and effective in improving 28-day mortality and controlling ventricular rate in patients with sepsis after fluid resuscitation, and has no significant adverse effect on tissue perfusion. PMID: 31756644 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31756644?dopt=Abstract

Source: Cytokine - November 18, 2019 Category: Molecular Biology Authors: Li J, Sun W, Guo Y, Ren Y, Li Y, Yang Z Tags: Cytokine Source Type: research